Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNPAT | O15228 | 1/20 | 0.70 |
| ▸ | FOLH1 | Q04609 | 8/20 | 0.56 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.56 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.56 |
| ▸ | BMP1 | P13497 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GGH | Q92820 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isospaglumic Acid SCHEMBL27542882 | 1.00 | GNPAT (0.70) | GNPATFOLH1NAALAD2RIMKLABMP1 | |
| SCHEMBL31194414 | 1.00 | GNPAT (0.70) | GNPATFOLH1NAALAD2RIMKLABMP1 | |
| Isospaglumic Acid SCHEMBL31121839 | 1.00 | GNPAT (0.70) | GNPATFOLH1NAALAD2RIMKLABMP1 | |
| Isospaglumic Acid SCHEMBL288515 | 1.00 | GNPAT (0.70) | GNPATFOLH1NAALAD2RIMKLABMP1 | |
| Isospaglumic Acid SCHEMBL6438535 | 0.98 | GNPAT (0.68) | GNPATFOLH1NAALAD2RIMKLABMP1 | |
| SCHEMBL29517621 | 0.94 | GNPAT (0.63) | GNPATFOLH1NAALAD2RIMKLABMP1 | |
| SCHEMBL13467302 | 0.93 | GNPAT (0.60) | GNPATFOLH1NAALAD2RIMKLABMP1 | |
| SCHEMBL17950968 | 0.93 | GNPAT (0.60) | GNPATFOLH1NAALAD2RIMKLABMP1 | |
| SCHEMBL19106177 | 0.93 | GNPAT (0.60) | GNPATFOLH1NAALAD2RIMKLABMP1 | |
| SCHEMBL2248714 | 0.93 | GNPAT (0.60) | GNPATFOLH1NAALAD2RIMKLABMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2385 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4737566-A1 | CAS12 PROTEIN AND USE THEREOF | Reforgene Medicine (CN) | 2026-05-06 | — | — | EP | claimed |
| EP-4692783-A1 | BIOMARKER AND SYSTEM FOR PREDICTING EVOLUTION INTO ACLF OR DEATH OF ACLF PATIENT, AND USES THEREOF | Shanghai Ganning Medical and Technology Co., Ltd (CN) | 2026-02-11 | — | — | EP | claimed |
| EP-4692338-A1 | CAS12 PROTEIN AND USE THEREOF | Guangzhou Reforgene Medicine Co., Ltd. (CN) | 2026-02-11 | — | — | EP | claimed |
| WO-2025199636-A1 | TARGETED RADIOLIGAND COMPOUNDS AND USES THEREOF | MCMASTER UNIVERSITY (CA) | 2025-10-02 | — | — | WO | claimed |
| EP-4619763-A1 | BIOMARKER PANEL FOR BRAIN SPECIFIC ABNORMAL NEUROLOGICAL CONDITIONS USING BIOFLUID SAMPLES | Gryphon Bio, Inc. (US) | 2025-09-24 | — | — | EP | claimed |
| WO-2025061113-A1 | CAS12 PROTEIN AND USE THEREOF | 广州瑞风生物科技有限公司 | 2025-03-27 | — | — | WO | claimed |
| CN-119510604-A | Biomarker for predicting whether ACLF patient will die, system and application thereof | 上海甘宁医疗科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119470683-A | Biomarker for predicting whether ACLF will be formed, system and application thereof | 上海甘宁医疗科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119320276-A | Ultralow-temperature sintered ceramic material and preparation method and application thereof | 肇庆学院 | 2025-01-17 | — | — | CN | claimed |
| EP-4475953-A1 | NMDAR ANTAGONISTS PREVENT AGEING AND AGING-ASSOCIATED CONDITIONS AND DISEASES THROUGH INCREASING 20S PROTEASOME ACTIVITY | SAHIN, Fikret (TR) | 2024-12-18 | — | — | EP | claimed |
| EP-1011327-A1 | TREATMENT OR PROPHYLAXIS OF RETINAL PATHOLOGY AND SPINAL CORD INJURY | Department of the Army, U.S. Governament U.S. Army Medical & Research and Materiel Command (US) | 2000-06-28 | — | — | EP | claimed |
| WO-2000024395-A1 | NEW USE OF GLUTAMATE ANTAGONISTS FOR THE TREATMENT OF CANCER | IKONOMIDOU HRISSANTHI (DE) | 2000-05-04 | — | — | WO | claimed |
| US-5981209-A | Use of NAALADase activity to identify prostate cancer and benign prostatic hyperplasia | GUILFORD PHARMACEUTICALS INC. (US) | 1999-11-09 | — | — | US | claimed |
| WO-1999032887-A1 | DETECTION OF PROSTATE DISEASE BY MEASURING NAALADASE ACTIVITY | GUILFORD PHARMACEUTICALS INC. (US) | 1999-07-01 | — | — | WO | claimed |
| WO-1999008521-A1 | TREATMENT OR PROPHYLAXIS OF RETINAL PATHOLOGY AND SPINAL CORD INJURY | DEPARTMENT OF THE ARMY, U.S. GOVERNMENT (US) | 1999-02-25 | — | — | WO | claimed |
| EP-0660707-A4 | METHOD OF PREVENTING NMDA RECEPTOR-MEDIATED NEURONAL DAMAGE. | CHILDRENS MEDICAL CENTER (US) | 1998-05-13 | — | — | EP | claimed |
| EP-0660707-A1 | METHOD OF PREVENTING NMDA RECEPTOR-MEDIATED NEURONAL DAMAGE | The Children's Medical Center Corporation (US) | 1995-07-05 | — | — | EP | claimed |
| WO-1994005275-A9 | METHOD OF PREVENTING NMDA RECEPTOR-MEDIATED NEURONAL DAMAGE | — | 1994-04-28 | — | — | WO | claimed |
| WO-1994005275-A1 | METHOD OF PREVENTING NMDA RECEPTOR-MEDIATED NEURONAL DAMAGE | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1994-03-17 | — | — | WO | claimed |
| WO-1992017168-A1 | METHOD OF PREVENTING NMDA RECEPTOR-MEDIATED NEURONAL DAMAGE | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1992-10-15 | — | — | WO | claimed |